|
Etonogestrel (implant)
|
Contraceptives
|
16-Aug-2023 |
|
Ethyl-epa
|
Drugs
|
16-Aug-2023 |
|
Ethosuximide
|
Succinimide anticonvulsants
|
16-Aug-2023 |
|
Ethionamide
|
Nicotinic acid derivatives
|
16-Aug-2023 |
|
Ethinyl estradiol-norethindrone and ferrous fumarate (24/4) (birth control)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol-norethindrone and ferrous fumarate (21/7) (birth control)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and segesterone (vaginal ring)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and norgestrel
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and norgestimate
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and norethindrone (hrt)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and norethindrone (birth control)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and norelgestromin (transdermal)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and levonorgestrel (transdermal)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and levonorgestrel (extended-cycle)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and levonorgestrel
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and etonogestrel (vaginal ring)
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and ethynodiol diacetate
|
Contraceptives
|
16-Aug-2023 |
|
Ethinyl estradiol and desogestrel
|
Contraceptives
|
16-Aug-2023 |
|
Ethanolamine oleate
|
Sclerosing agents
|
16-Aug-2023 |
|
Ethanol topical
|
Antiseptic and germicides
|
16-Aug-2023 |
|
Ethacrynic acid
|
Loop diuretics
|
16-Aug-2023 |
|
Estropipate
|
Estrogens
|
16-Aug-2023 |
|
Estramustine
|
Hormones / antineoplastics
|
16-Aug-2023 |
|
Estradiol, norethindrone, and relugolix
|
Sex hormone combinations
|
16-Aug-2023 |
|
Estradiol vaginal (local)
|
Estrogens
|
16-Aug-2023 |
|
Estradiol vaginal
|
Estrogens
|
16-Aug-2023 |
|
Estradiol transdermal (skin patch)
|
Estrogens
|
16-Aug-2023 |
|
Esomeprazole strontium
|
Proton pump inhibitors
|
16-Aug-2023 |
|
Erythromycin topical
|
Topical acne agents
|
16-Aug-2023 |
|
Erythromycin (systemic) (monograph)
|
Drugs
|
16-Aug-2023 |
|
Erythromycin (eent) (monograph)
|
Drugs
|
16-Aug-2023 |
|
Ertugliflozin and sitagliptin
|
Antidiabetic combinations
|
16-Aug-2023 |
|
Ertugliflozin and metformin
|
Antidiabetic combinations
|
16-Aug-2023 |
|
Erlotinib
|
EGFR inhibitors
|
16-Aug-2023 |
|
Eribulin
|
Mitotic inhibitors
|
16-Aug-2023 |
|
Ergotamine
|
Antimigraine agents
|
16-Aug-2023 |
|
Ergoloid mesylates
|
Miscellaneous central nervous system agents
|
16-Aug-2023 |
|
Erenumab
|
CGRP inhibitors
|
16-Aug-2023 |
|
Eptinezumab
|
CGRP inhibitors
|
16-Aug-2023 |
|
Eptifibatide
|
Glycoprotein platelet inhibitors
|
16-Aug-2023 |
|
Epoprostenol
|
Agents for pulmonary hypertension
|
16-Aug-2023 |
|
Epoetin beta and methoxy polyethylene glycol
|
Recombinant human erythropoietins
|
16-Aug-2023 |
|
Epoetin alfa
|
Recombinant human erythropoietins
|
16-Aug-2023 |
|
Epirubicin
|
Antibiotics / antineoplastics
|
16-Aug-2023 |
|
Entrectinib
|
Multikinase inhibitors
|
16-Aug-2023 |
|
Entacapone
|
Dopaminergic antiparkinsonism agents
|
16-Aug-2023 |
|
Enpresse
|
Contraceptives
|
16-Aug-2023 |
|
Enfuvirtide
|
Miscellaneous antivirals
|
16-Aug-2023 |
|
Enfortumab vedotin
|
Miscellaneous antineoplastics
|
16-Aug-2023 |
|
Enbrel sureclick
|
Antirheumatics
|
16-Aug-2023 |
|
Enbrel mini prefilled cartridge
|
Antirheumatics
|
16-Aug-2023 |
|
Emu oil
|
Drugs
|
16-Aug-2023 |
|
Emtricitabine, rilpivirine, and tenofovir
|
Antiviral combinations
|
16-Aug-2023 |
|
Emtricitabine, nelfinavir, and tenofovir
|
Antiviral combinations
|
16-Aug-2023 |
|
Duraflex (msm)
|
Nutraceutical products
|
16-Aug-2023 |
|
Duoplant
|
Topical acne agents
|
16-Aug-2023 |
|
Dextrose 5% in water (d5w)
|
Glucose elevating agents
|
16-Aug-2023 |
|
Dextromethorphan, guaifenesin, and pseudoephedrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan, guaifenesin, and phenylephrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan, diphenhydramine, and phenylephrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan and quinidine
|
Miscellaneous central nervous system agents
|
16-Aug-2023 |
|
Dextromethorphan and pyrilamine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan and pseudoephedrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan and promethazine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan and phenylephrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan and guaifenesin
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextromethorphan and doxylamine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dextranomer and sodium hyaluronate
|
Miscellaneous uncategorized agents
|
16-Aug-2023 |
|
Dextran (high molecular weight)
|
Plasma expanders
|
16-Aug-2023 |
|
Dexrazoxane
|
Miscellaneous uncategorized agents
|
16-Aug-2023 |
|
Dexmethylphenidate and serdexmethylphenidate
|
CNS stimulants
|
16-Aug-2023 |
|
Dexmethylphenidate
|
CNS stimulants
|
16-Aug-2023 |
|
Dexmedetomidine (buccal/sublingual)
|
Miscellaneous anxiolytics, sedatives and hypnotics
|
16-Aug-2023 |
|
Dexmedetomidine
|
Miscellaneous anxiolytics, sedatives and hypnotics
|
16-Aug-2023 |
|
Dexlansoprazole
|
Proton pump inhibitors
|
16-Aug-2023 |
|
Dexchlorpheniramine, dextromethorphan, and pseudoephedrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dexchlorpheniramine and pseudoephedrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dexchlorpheniramine and phenylephrine
|
Upper respiratory combinations
|
16-Aug-2023 |
|
Dexchlorpheniramine
|
Antihistamines
|
16-Aug-2023 |
|
Dexbrompheniramine, dextromethorphan, and pseudoephedrine
|
Upper respiratory combinations
|
16-Aug-2023 |
